ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $772,000 | +63.6% | 5,000 | +19.2% | 0.21% | +18.3% |
| Q1 2020 | $472,000 | -32.2% | 4,195 | -16.1% | 0.18% | +63.6% |
| Q4 2019 | $696,000 | -27.7% | 5,000 | -50.0% | 0.11% | -20.1% |
| Q3 2019 | $963,000 | -16.4% | 10,000 | 0.0% | 0.13% | 0.0% |
| Q2 2019 | $1,152,000 | -2.1% | 10,000 | 0.0% | 0.13% | +38.1% |
| Q1 2019 | $1,177,000 | +87.7% | 10,000 | 0.0% | 0.10% | +83.0% |
| Q4 2018 | $627,000 | -11.6% | 10,000 | 0.0% | 0.05% | +17.8% |
| Q3 2018 | $709,000 | +6.6% | 10,000 | 0.0% | 0.04% | +4.7% |
| Q2 2018 | $665,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |